Purpose
febrile neutropenia, breast cancer
FEBRILE NEUTROPENIA, BREAST CANCER
Evaluate the safety and efficacy of efbemalenograstim alfa for reducing the risk of febrile neutropenia in breast cancer patients undergoing myelosuppressive chemotherapy.